Ilex Clolar Efficacy Plus Transplant Success Is Likely Focus For Cmte. Review
This article was originally published in The Pink Sheet Daily
Executive Summary
One important issue will be the percentage of patients who have a successful transplant after responding to Clolar, briefing documents state. For patients who do not have a transplant, success depends on response duration, survival, toxicity and results achievable with other therapy. Study size is also likely topic for the committee.